Purchase Order HHSN269201800114P

<p>The NIH Clinical Center awarded a purchase order to Biomerieux Inc. on April 16, 2018, for $9,166.20 with a firm fixed price structure and no set-aside designation. Place of performance is Bethesda, Maryland. The order ceiling is due for ultimate completion on April 17, 2018. The source does not specify the detailed scope of supplies or services being procured under this purchase order.</p>

<p>The NIH Clinical Center awarded a purchase order to Biomerieux Inc. on March 30, 2018, for $14,285.84 with a firm fixed-price structure and an ultimate completion date of April 29, 2018. Place of performance is Bethesda, Maryland. The order procures in vitro diagnostic equipment, reagents, or test kits—Biomerieux's core offerings in microorganism identification and clinical laboratory testing. No set-aside was applied to this acquisition.</p>

<p>The NIH Clinical Center awarded a purchase order to Biomerieux Inc. for $14,703.00 on April 16, 2019, with completion targeted for April 15, 2020. Work is performed in Bethesda, Maryland. The order is firm fixed price with no set-aside designation. The specific requirements are not detailed in the source material.</p>

<p>The NIH Clinical Center awarded a purchase order to Biomerieux Inc. on May 29, 2018, with a ceiling value of $9,544.74. The order carries firm fixed-price terms and no set-aside designation. Place of performance is Bethesda, Maryland. The ultimate completion date is June 8, 2018.</p>

The NIH Clinical Center issued a purchase order to Biomerieux Inc. on July 20, 2018, with a ceiling value of $263,153.78 for firm fixed-price diagnostic supplies and equipment. The order was administratively de-obligated on a de-obligation notice dated July 20, 2018, to close unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 close of the period of availability. Place of performance is Bethesda, Maryland. The...

<p>The NIH Clinical Center awarded a purchase order to Biomerieux Inc. on September 19, 2017, with a ceiling value of $9,730.09. No set-aside was used. Place of performance is Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of September 29, 2017. The solicitation number is 17-016281.</p>

The National Institutes of Health Clinical Center issued a purchase order to Biomerieux Inc. on July 2, 2020, with a ceiling value of $20,986.60 and an ultimate completion date of July 10, 2020. The order carries firm fixed-price pricing and no set-aside designation. Performance takes place in Durham, North Carolina. The purchase order procures diagnostic equipment, reagents, or test kits from Biomerieux's portfolio of microbiological testing and in vitro diagnostic solutions, including its...

Biomerieux Inc. was awarded a purchase order valued at $24,995.61 by the NIH Clinical Center on July 9, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price contract represents a direct procurement with no set-aside designation. The NIH Clinical Center, a component of the National Institutes of Health, procures specialized diagnostic and laboratory solutions to support its clinical research and patient care missions. Biomerieux, operating under the trade name Vitek...

This is a $75,025.40 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biomerieux Inc., a global leader in in vitro diagnostics and laboratory testing solutions. The contract is for the supply of reagents and supplies required for molecular patient care testing, with a period of performance ending on February 8, 2022. The contract does not have a set-aside designation. Biomerieux Inc. is the prime contractor, and there is no information...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $24,663 purchase order to Biomerieux Inc. for BIOFIRE MYCOPLASMA ASSAY REAGENTS. The contract has a period of performance from July 27, 2023 through December 7, 2023 and utilizes a firm fixed price payment structure. Biomerieux Inc. will provide assay reagents to support diagnostic testing needs at the NIH Clinical Center in Bethesda, Maryland. No subcontractors or set aside designations were...